Yahoo Finance Better Bear Market Buy: Nvidia vs. AMD Stock
After brutal trading last year, both stocks are rallying. But which leading chip company is the better investment?
After brutal trading last year, both stocks are rallying. But which leading chip company is the better investment?
Wall Street is under pressure this morning as investors digest recent headlines out of Washington, including recent messaging from the Fed and a possible government shutdown. In Michigan, President Biden is set to visit UAW members as strikes continue at General Motors (GM), Ford (F), and Stellantis (STLA). Former Vice President Mike Pence will join Yahoo Finance Live at 10 a.m. ET to discuss the shutdown, the upcoming GOP debate, inflation, and much more. Trending tickets today include DraftKings (DKNG), Williams-Sonoma (WSM), and Sea Limited (SE).Top guests today include:9a.m. ET - Gargi Chaudhuri, BlackRock head of iShares investment strategy9:40 a.m ET - Kenny Polcari, Slatestone Wealth Management Chief Market Strategist10 a.m. ET - Former Vice President Mike Pence11 a.m. ET - Steve Schmidt, Political Strategist11:15 a.m. ET - Octavio Marenzi, Opimas CEO
Change in ELF Score at 12 Weeks in INTEGRIS-PSC Change in ELF Score at 12 Weeks in INTEGRIS-PSC Bexotegrast (PLN-74809) was well tolerated over 12 weeks of treatment with few discontinuations and no drug-related severe or serious adverse events Bexotegrast reduced both the Enhanced Liver Fibrosis (ELF) score and collagen synthesis biomarker PRO-C3 levels relative to placebo at all doses with statistical significance at the 160 mg dose Bexotegrast-treated patients showed improved liver biochemist
Prominent Nonvenereal Syphilis Treatment Market players include Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis International AG, Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, and Cipla Limited,New York, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The global nonvenereal syphilis treatment market size is predicted to grow at a CAGR of over ~9% from 2023 to 2035. The market is projected to garner a revenue of USD 440 milli
Q3 2023 consolidated revenue of $20.9 million, adjusted EBITDA of $2.2 millionsBLA for F8 formulation of tesamorelin submitted to FDAAgreement in principle on key amendments to loan facility with Marathon MONTREAL, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today reported business highlights and financial results for
GAITHERSBURG, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Louis J. Aronne, Founder and Director of the Center for Weight Management at Weill-Cornell Medical Center, and a leading authority in obesity, will present the results of its 24-week clinical trial of pemvidutide in the treatment of subjects with overweight or obesity in an oral presentation at the 59th Annual Meeting of the European Associatio
Not for Distribution to United States Newswire Services or for Dissemination in the United StatesVANCOUVER, British Columbia, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Deep-South Resources Inc. ("Deep-South" or the Company) (TSX-V: DSM) announces that the Company closed the second tranche of its oversubscribed non-brokered private placement (“Private Placement”) for an amount totaling $1,803,282. The first tranche closed September 6, 2023 for an amount of $265,447. The two tranches together total $2,06
MONTREAL, Sept. 26, 2023 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials is pleased to announce that HPQ and its Lyon-based affiliate, Novacium SAS, have signed a three-party memorandum of understanding (MOU) with LN INNOV’ SAS of Toulouse, France. LN INNOV’ is a French networking company with a strong presence in various sectors, including Defense. L
Study Met Primary Endpoint; Highly Statistically Significant Difference in Change from Baseline in HQ-CT Total Score for DCCR Compared to Placebo (p=0.0022) Soleno Intends to Submit a New Drug Application for DCCR in PWS Mid-Year 2024 Company to Host Conference Call and Webcast Today at 9:00 AM ET REDWOOD CITY, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- September 26, 2023 – Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics
Efficacy Chart Efficacy results in both cohorts at baseline and at Week 4 following the dose of SPL026 with support therapy • Results suggest that SSRIs enhance the efficacy of SPL026 (DMT) when administered to MDD patients on a stable dose of SSRIs versus patients not on SSRIs • At Week 4, 100% of patients in the SSRI cohort responded to SPL026 (DMT) with 92% of patients in remission from depression • No apparent differences in the safety and tolerability profile of SPL026 (DMT) following admin
WINTER PARK, Fla., Sept. 26, 2023 (GLOBE NEWSWIRE) -- CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the third quarter of 2023 after the market closes on Thursday, October 26, 2023. A conference call to discuss its financial and operating results is scheduled for Friday, October 27, 2023 at 9:00 AM ET. A live webcast of the call will be available on the Investor Relations page of the Company’s website at www.ctoreit.com o
Marina Golubeva and Ali Rakib join the company as the Digital Trade and Supply Chain Finance provider expands its lending portfolio in both emerging and developed marketsDUBAI, United Arab Emirates, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Triterras, Inc. (“Triterras” or the “Company”) a leading fintech company focused on trade and trade finance, announces the hiring of two new members to the Distribution team. Marina Golubeva and Ali Rakib will engage with institutional investors who are interested i
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today announced that it will host a Research & Development (R&D) Day investor event on Monday, October 2, 2023. The event will take place at the Company’s headquarters in New York’s Hudson Yards from 12:00 pm - 2:30 pm and will be webcast simultaneously. Ovid management w
FREMONT, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will report financial results for its first quarter of fiscal 2024 ended August 31, 2023 on Thursday, October 5, 2023 following the close of the market. The Company will host a conference call and webcast at 5:00 p.m. Eastern time to discuss the results. What: Aehr Test Systems first quarter fiscal 2024 financial results c
The food service industry rebounded to pre-crisis levels, driven by a surge in delivery sales. Markets grew significantly, partly due to population growth. The rise of online food delivery services highlighted a shift towards convenience, urging the industry to adapt. Additionally, there's a growing demand for vegetarian, vegan, and plant-based options.NEWARK, Del, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The global food service industry size is likely to jump from US$ 3,483,539.5 million in 2023 to U
Proposed acquisition adds market leading magnetic mixing technology for upstream and downstream bioprocess applicationsExpands Repligen’s Fluid Management portfolio, complements single-use bag offering WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a definitive agreement to acquire privately-held Metenova AB (Metenova) of Mölndal, Sweden. Meteno
WINTER PARK, Fla., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for the third quarter of 2023 after the market closes on Thursday, October 19, 2023. A conference call to discuss its financial and operating results is scheduled for Friday, October 20, 2023 at 9:00 AM ET. A live webcast of the call will be available on the Investor Relations page of the Company’s website at
- Data from ongoing trial suggest clinical benefit for ENPP1 Deficiency, including improvement in key biomarkers, patient reported outcomes (PROs) and functional outcomes - - Improvement in the Global Impression of Change (GIC) observed in all three dose cohorts in ABCC6 Deficiency (PXE) trial - - INZ-701 was generally well tolerated and exhibited a favorable safety and immunogenicity profile in both trials - - Company to host conference call and webcast today at 8:00 a.m. ET - BOSTON, Sept. 26,
BEIJING, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Fang Holdings Limited (OTC: SFUNY) (“Fang” or the “Company”), a leading real estate Internet portal in China, today announced that its board of directors (the “Board”) has formed a special committee (the “Special Committee”) consisting of three independent directors, Mr. Huyue Zhang, Mr. Shaohua Zhang and Mr. Changming Yan, to evaluate and consider the previously announced preliminary non-binding acquisition proposal letter dated September 4, 2023 (the
The Award Recognizes Lincoln Electric’s Stewardship and Commitment to Operational Excellence Lincoln Electric Named to Newsweek's America's Greenest Companies 2024 Ranking Lincoln Electric named as one of America's Greenest Companies in 2024 by Newsweek. CLEVELAND, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Lincoln Electric Holdings, Inc., (Nasdaq: LECO) is pleased to announce today that is has been recognized as one of America’s Greenest Companies 2024 by Newsweek, market research firm Plant-A Insights
CHICAGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the third quarter ending September 30, 2023, before the market opens on Wednesday, November 8, 2023. A conference call and webcast with analysts and investors is scheduled for November 8, 2023 at 8:30 a.m. ET / 7:30 a.m. CT to discuss the results and answer investor and part